Kristen Oelschlager M.'s most recent trade in Castle Biosciences Inc was a trade of 47,838 Restricted Stock Units done . Disclosure was reported to the exchange on March 4, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 47,838 | 47,838 | - | - | Restricted Stock Units | |
Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 13,811 | 41,432 | - | - | Restricted Stock Units | |
Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 13,811 | 167,604 (0%) | 0% | - | Common Stock | |
Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.23 per share. | 04 Mar 2025 | 3,640 | 163,964 (0%) | 0% | 22.2 | 80,917 | Common Stock |